Articles

Youth Code Jam Pitch Perfect at Philanthropitch San Antonio
Articles, Featured

Youth Code Jam Pitch Perfect at Philanthropitch San Antonio

Six finalists took turns pitching innovative solutions to local community challenges Tuesday evening at the Tobin Center. The judges and audience listened as each spoke about their respective social impact venture at Philanthropitch, a fast-pitch event that connects nonprofits with mentors and capital to help them scale to sustainable funding models. A panel of investors donate their own money, then decide how it should be distributed among the finalists. All ticket proceeds from the event go to the nonprofit that wins the "audience's choice" award. Of the $110,000 available from a combination of awards from sponsors, judges, and the audience’s choice, one founder garnered almost half the event’s amount. Debi Pfitzenmaier, CEO of Youth Code Jam had collected eight different checks total...
Seasoned Entrepreneurs on the State of San Antonio’s Startups
Articles, Featured

Seasoned Entrepreneurs on the State of San Antonio’s Startups

Local ‘techpreneurs’ were in the audience and on the panels at San Antonio Tech: Seizing the Momentum, Xconomy's first public event in San Antonio. The half-day forum at the Pearl Stables united some of Central Texas’s most successful entrepreneurs and innovative technologists to discuss San Antonio's tech ecosystem and its future prospects. For a company that has grown from three Trinity University students founding a startup in 1998 to the industry leader in the multicloud managed service market as independently assessed by Gartner analysts, Rackspace is the indisputable anchor in San Antonio’s tech community. Rackspace’s chief operating officer David Meredith focused on the company’s vision of a seamless single “pane of glass” across public and private cloud computing that provide...
Texas BioMed Explores Malaria in Latest Podcast
Articles, Sponsored Post

Texas BioMed Explores Malaria in Latest Podcast

Malaria is a mosquito-borne disease that kills hundreds of thousands of people around the world every year. Texas Biomed's own scientist Ian Cheeseman, Ph.D., and his team at specialize in the genetics of the parasite that causes malaria. Listen to Texas BioMed's latest podcast episode 2, Much Ado About Malaria, from TXBiobytes. His newest study published in the journal Genome Biology and Evolution was recently highlighted in the Editors Choice section of the prestigious journal Science. “At the basic level we simply do not know what’s in a malaria infection, even though this has profound implications for how we think about treating and eradicating this disease,” Cheeseman said. Using various technologies, these scientists are literally cracking open cells and using single cell DNA seq...
Five Stories From San Antonio’s Thriving Bioscience Industry
Articles

Five Stories From San Antonio’s Thriving Bioscience Industry

From companies commercializing a cancer prevention drug and urological medical device, to reintroducing transfusion methods and working on a new vaccine and chromosomal abnormalities research, the Health Cell’s annual State of the Industry 2018 event Feb. 6 highlighted San Antonio’s thriving bioscience sector. “This is our fourth annual event,” Health Cell co-founder Beth Eby said. "We aim for a good representation of those ‘who knew?’ stories from San Antonio’s bioscience and healthcare sector." The five stories reflect how innovators in San Antonio are significantly advancing the understanding of critical issues in the life sciences, having a substantial impact on public health, or highlighting pressing health care issues. New Cancer Prevention Drug Boosts Body’s Immune System ...
Rapamycin Holdings, Inc.
Articles, Featured

Rapamycin Holdings, Inc.

San Antonio-based Rapamycin Holdings, Inc. (RHI) is bringing a ground-breaking cancer prevention drug to market. The drug company is commercializing eRapa, a novel, proprietary reformulation of the generic drug Rapamycin. Hailed as the 2009 scientific “Breakthrough of the Year” by Science magazine, eRapa is the first drug proven to extend life span in mammals, on average by 20 percent.  The July 2009 issue of Nature reported that eRapa boosts health and longevity in mice, the first time any drug has extended a mammal’s life span. Rapamycin is an antibiotic derived from microbes discovered in the soils of Easter Island in 1972 and was approved by the Food and Drug Administration (FDA) in 1999 as an immunosuppressant. It has long been used by transplant patients to help fight organ rej...